Boric Acid (99.9% Granular) - Peru CAS: 10043-35-3
Related Insights
Force Majeure Declarations Loom: What Chemical Procurement Teams Should Know About Contract Risk
Prolonged geopolitical disruption is increasing the likelihood of force majeure declarations across energy and chemical supply chains. Procurement and legal teams should review contracts, supplier obligations and contingency plans before disruptions escalate.
Japan's China Fatigue: Why Chemical Makers Are Redirecting Investment to India
Japanese chemical manufacturers are shifting investment away from China toward India after years of deepening engagement in Chinese markets. The pivot centers particularly on solar materials and reflects broader frustrations with operating conditions in China that procurement teams managing Asian supply chains must understand as sourcing patterns reshape across the region.
Naphtha Supply Halted: How Asia's Petrochemical Makers Are Responding to Hormuz Disruptions
The disruption of naphtha shipments through the Strait of Hormuz has placed renewed pressure on Asia's petrochemical industry. Buyers of olefins, polymers and downstream petrochemicals should reassess feedstock exposure and supplier resilience as market conditions evolve.
Global Chemical Production: What the IMF's 2026 Regional Economic Outlook Means for Chemical Supply Chains
The IMF's April 2026 Regional Economic Outlook highlights the strategic importance of the Strait of Hormuz to global oil, helium, sulfur, ammonia and petrochemical feedstock flows. Chemical procurement teams can use this multilateral data to strengthen supply chain risk assessments and executive decision making.
Algal Oil and Marine Bio-Based Ingredients: A Hormuz-Independent Supply Strategy for Food Ingredient Buyers
Fermentation-based marine ingredients such as algal DHA, astaxanthin and beta-glucan offer food manufacturers a more resilient supply chain during periods of global shipping disruption. Procurement teams should understand why production geography matters as much as ingredient performance.
DMF Supply Tightness: Pharmaceutical & GLP‑1 Demand Drives Market Shift
Pharmaceutical‑grade dimethylformamide is entering a period of stronger demand as API manufacturing recovers and GLP‑1 peptide production expands. The rising demand creates supply risks that procurement teams must address before tighter market conditions emerge in 2026. This article outlines the drivers, risks, and sourcing strategies for securing DMF.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.